Pharmacokinetics of tapentadol in laying hens and its residues in eggs after multiple oral dose administration

References

• Bartlet, A. L., and L. M. Kirinya. 1976. “Activities of Mixed Function Oxidares, UDP-glucuromyl Thansferare and Sulphate Conjugation Enzymes in Galliformes and Anseriformes.” Quarterly Journal of Experimental Physiology 61: 105–119. doi:10.1113/expphysiol.1976.sp002341.
   PubMed Web of Science ®Google Scholar
• Bomzon, A. 2011. “Pain and Stress in Cattle: A Personal Prospective.” Israel Journal of Veterinary Medicine 66: 12–20.
   Web of Science ®Google Scholar
• De Vito, V. 2015. “Non-Steroidal Anti-Inflammatory Drugs in Food Producing Animals.” American Journal of Animal and Veterinary Sciences 10: 85.90.
   Google Scholar
• Giorgi, M. 2012. “Tramadol Vs Tapentadol: A New Horizon in Pain Treatment?” American Journal of Animal and Veterinary Sciences 7: 7–11. doi:10.3844/ajavsp.2012.7.11.
   Google Scholar
• Giorgi, M., A. Meizler, and P. C. Mills. 2012a. “Quantification of Tapentadol in Canine Plasma by HPLC with Spectrofluorimetric Detection: Development and Validation of a New Methodology.” Journal of Pharmaceutical and Biomedical Analysis 67-68: 148–153. doi:10.1016/j.jpba.2012.04.020.
   PubMed Web of Science ®Google Scholar
• Giorgi, M., A. Meizler, and P. C. Mills. 2012b. “Pharmacokinetics of the Novel Atypical Opioid Tapentadol following Oral and Intravenous Administration in Dogs.” The Veterinary Journal 194: 309–313. doi:10.1016/j.tvjl.2012.05.019.
   PubMed Web of Science ®Google Scholar
• Giorgi, M., and H. Yun. 2012. “Pharmacokinetics of Mirtazapine and Its Main Metabolites in Beagle Dogs: A Pilot Study.” The Veterinary Journal 192: 239–241. doi:10.1016/j.tvjl.2011.05.010.
   PubMed Web of Science ®Google Scholar
• Giorgi, M., H. K. Lee, S. Rota, H. Owen, V. De Vito, M. P. Demontis, and M. V. Varoni. 2015. “Pharmacokinetic and Pharmacodynamic Assessments of Tapentadol in Yellow-Bellied Slider Turtles (Trachemys scripta scripta) after a Single Intramuscolar Injection.” Journal of Exotic Pet Medicine 24: 317–325. doi:10.1053/j.jepm.2015.06.004.
   Web of Science ®Google Scholar
• Giorgi, M., P. C. Mills, H. Tayari, S. Rota, G. Breghi, and A. Briganti. 2013. “Plasma Concentrations of Tapentadol and Clinical Evaluations of a Combination of Tapentadol Plus Sevoflurane for Surgical Anaesthesia and Analgesia in Rabbits (Oryctolagus Cuniculus) Undergoing Orchiectomy.” Israel Journal of Veterinary Medicine 68: 141–148.
   Web of Science ®Google Scholar
• Giorgi, M., V. De Vito, R. Raushanova, K. Lubov, and H. Owen. 2016. “Analgesic Use in Farm Animals by Kazakhstani Veterinarians and Farmers.” Israel Journal of Veterinary Medicine 71: 3–9.
   Web of Science ®Google Scholar
• Goetting, V., K. A. Lee, and L. A. Tell. 2011. “Pharmacokinetics of Veterinary Drugs in Laying Hens and Residues in Eggs: A Review of the Literature.” Journal of Veterinary Pharmacology and Therapeutics 34: 521–556. doi:10.1111/jvp.2011.34.issue-6.
   PubMed Web of Science ®Google Scholar
• Lavy, E., H. K. Lee, S. J. Mabjeesh, C. Sabastian, Y. Baker, and M. Giorgi. 2014. “Use of the Novel Atypical Opioid Tapentadol in Goats (Capra Hircus): Pharmacokinetics after Intravenous, and Intramuscular Administration.” Journal of Veterinary Pharmacology and Therapeutics 37: 518–521. doi:10.1111/jvp.12123.
   PubMed Web of Science ®Google Scholar
• Lee, H. K., B. Lebkowska-Wieruszuska, T. W. Kim, C. J. Kowaski, and M. Giorgi. 2013. “Pharmokinetics of the Novel Atypical Opoid Tapentodol after Intravenous, Intramuscular and Subcutaneous Administration in Cats.” The Veterinary Journal 198: 620–624. doi:10.1016/j.tvjl.2013.09.011.
   PubMed Web of Science ®Google Scholar
• Lin, Z., M. Cuneo, J. D. Rowe, M. Li, L. A. Tell, S. Allison, J. Carlson, J. E. Riviere, and R. Gehring. 2016. “Estimation of Tulathromycin Depletion in Plasma and Milk after Subcutaneous Injection in Lactating Goats Using a Nonlinear Mixed-Effects Pharmacokinetic Modeling Approach.” BMC Veterinary Research 12: 258. doi:10.1186/s12917-016-0884-4.
   PubMed Web of Science ®Google Scholar
• Nasr, M. A. F., C. J. Nicol, L. Wilkins, and J. C. Murrell. 2015. “The Effects of Two Non-Steroidal Anti-Inflammatory Drugs on the Mobility of Laying Hens with Keel Bone Fractures.” Veterinary Anaesthesia and Analgesia 42: 197–204. doi:10.1111/vaa.12175.
   PubMed Web of Science ®Google Scholar
• Nasr, M. A. F., C. J. Nicoli, and J. C. Murrell. 2012a. “Do Laying Hens with Keel Bone Fractures Experience Pain?” Plos One 7: 1–5. doi:10.1371/journal.pone.0042420.
   Web of Science ®Google Scholar
• Nasr, M. A. F., J. C. Murrell, L. Wilkins, and C. J. Nicol. 2012b. “The Effect of Keel Fractures on Egg-Production Parameters, Mobility and Behaviour in Individual Laying Hens.” Animal Welfare 21: 127–135. doi:10.7120/096272812799129376.
   Web of Science ®Google Scholar
• Nasr, M. A. F., W. J. Brownea, G. Caplena, B. Hothersalla, J. C. Murrella, and C. J. Nicol. 2013. “Positive Affective State Induced by Opioid Analgesia in Laying Hens with Bone Fractures.” Applied Animal Behaviour Science 147: 127–131. doi:10.1016/j.applanim.2013.04.015.
   Web of Science ®Google Scholar
• Pasero, C. 2011. “Tapentadol for Multimodal Pain Management.” Journal of PeriAnesthesia Nursing 26: 343–346. doi:10.1016/j.jopan.2011.06.001.
   PubMed Web of Science ®Google Scholar
• Soars, M. G., D. J. Smith, R. J. Riley, and B. Burchell. 2001. “Cloning and Characterization of a Canine UDP-glucuronosyltransferase.” Archives of Biochemistry and Biophysics, 391: 218–224. doi:10.1006/abbi.2001.2383.
   PubMed Web of Science ®Google Scholar
• Taylor, P. M., S. A. Robertson, M. J. Dixon, M. Ruprah, J. W. Sear, B. D. X. Lascelles, C. Waters, and M. Bloomfield. 2001. “Morphine, Pethidine and Buprenorphine Disposition in the Cat.” Journal of Veterinary Pharmacology and Therapeutics 24: 391–398. doi:10.1046/j.1365-2885.2001.368goblin.x.
   PubMed Web of Science ®Google Scholar
• Terlinden, R., J. Ossig, F. Fliegert, C. Lange, and K. Göhler. 2007. “Absorption, Metabolism, and Excretion of 14c-Labeled Tapentadol HCl in Healthy Male Subjects.” European Journal of Drug Metabolism and Pharmacokinetic 32: 163–169. doi:10.1007/BF03190478.
   PubMed Web of Science ®Google Scholar
• Toutain, P. L., and P. Lees. 2004. “Integration and Modelling of Pharmacokinetic and Pharmacodynamic Data to Optimize Dosage Regimens in Veterinary Medicine.” Journal of Veterinary Pharmacology and Therapeutics 27: 467–477. doi:10.1111/jvp.2004.27.issue-6.
   PubMed Web of Science ®Google Scholar
• Tzschentke, T. M., T. Christoph, B. K€Ogel, K. Schiene, H. H. Hennies, W. Englberger, M. Haurand, et al. 2007. “(-)-(1r,2r)-3-(3-Dimethylamino-1-Ethyl-2- Methyl-Propyl)-Phenol Hydrochloride (Tapentadol HCl): A Novel Muopioid Receptor Agonist/Norepinephrine Reuptake Inhibitor with Broad-Spectrum Analgesic Properties.” Journal of Pharmacology and Experimental Therapeutics 323: 265–276. doi:10.1124/jpet.107.126052.
   PubMed Web of Science ®Google Scholar
• Tzschentke, T. M., U. Jahnel, B. K€Ogel, T. Christoph, W. Englberger, J. De Vry, K. Schiene, et al. 2009. “Tapentadol Hydrochloride: A Next-Generation, Centrally Acting Analgesic with Two Mechanisms of Action in a Single Molecule.” Drugs of Today 45: 483–496.
   PubMed Web of Science ®Google Scholar